Uterine Cancer
📧 Sign up to get email alerts when something new happens for Uterine Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: [18F]FES PET/.CT in Uterine Cancer [Phase 2]
A Phase 2 clinical trial evaluating [18F]FES PET/CT imaging for uterine cancer is currently recruiting at the Abramson Cancer Center (Penn M…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) [NA]
A clinical trial update for a physical activity intervention (Fit4Treatment) in older women with gynecologic cancers, currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Study of NEO-201 in Solid Tumors Expansion Cohorts [Phase 1, Phase 2]
Precision Biologics is expanding cohorts in a Phase 1/2 study of NEO-201 in solid tumors, including non-small cell lung cancer, head and nec…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS) [NA]
Completed feasibility testing of the Informed Symptom Management System (PRISMS) for collecting patient-reported outcomes in cancer patients…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery [NA]
A completed clinical trial evaluating a rapid triadic communication intention elicitation intervention to improve supportive oncology care d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
A clinical trial evaluating salivary RNA in subjects scheduled for gynecologic pathology surgery is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of Nivolumab in Selected Uterine Cancer Patients [Phase 2]
Phase 2 study of Nivolumab in selected uterine cancers has completed enrollment and posted results in 2024.
-
CLINICAL_TRIALS withdrawal · 2024-12-19Clinical Trial Update: Niraparib in High-grade Endometrial Cancer Trial [EARLY_Phase 1]
A Phase 1 Niraparib trial for high-grade endometrial cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations [Phase 2]
Phase 2 basket trial evaluating tucatinib in combination with trastuzumab across HER2-altered solid tumors, with results posted for several …
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Trial status update indicates that a study using ultrasound-guided Tru-Cut biopsy for pelvic masses is recruiting, involving patients with o…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer (UTUC)
A completed clinical trial update from Taipei Tzu Chi Hospital assessing treatment and prognosis for upper tract urothelial carcinoma. The r…
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors [Phase 1]
Phase 1 results for a study combining the TORC1/2 inhibitor MLN0128 (sapanisertib) with bevacizumab in adults with recurrent glioblastoma or…
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers [Phase 2]
Phase 2 trial update on atezolizumab and Vigil in advanced gynecological cancers, including ovarian, cervical, and uterine cancers, with com…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of GEN1044 (DuoBody-CD3x5T4) in malignant solid tumors has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: Effect of Hemp-CBD on Patients With CIPN [Phase 2]
Phase 2 clinical trial investigating the effect of hemp-derived CBD on chemotherapy-induced peripheral neuropathy.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Image-Guided Gynecologic Brachytherapy [Phase 2]
Phase 2 clinical trial update for image-guided gynecologic brachytherapy in cervical and uterine cancers.
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer [Phase 2]
Phase 2 clinical trial update on pembrolizumab with radiation and an immune modulatory cocktail in cervical and endometrial/uterine cancers …
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. [Phase 4]
Phase 4 trial comparing oral iron to placebo in newly diagnosed gynecologic oncology patients who are surgical candidates; completed.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers [Phase 2]
Phase 2 pilot study evaluating durvalumab with Vigil in advanced women's cancers has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma [Phase 1, Phase 2]
Clinical trial update for Gleevec/Taxol in uterine papillary serous carcinoma (phase 1/2) has terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma [Phase 2]
Phase 2 trial evaluating radiation therapy combined with paclitaxel and carboplatin for uterine papillary serous carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 3]
Phase 3 trial evaluating paclitaxel and carboplatin versus ifosfamide in newly diagnosed, persistent, or recurrent uterine, ovarian, fallopi…
-
CLINICAL_TRIALS research · 2020-02-05Clinical Trial Update: Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation [Phase 2, Phase 3]
Clinical trial update detailing a treatment plan for a recurrent uterine papillary serous carcinoma with a PIK3CA mutation; phases 2 and 3 c…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer [Phase 2]
Phase 2 clinical trial evaluating PD-1 monoclonal antibody SHR-1210 in combination with apatinib for advanced non-small cell lung cancer, so…